Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fighting Cock Performance Transcriptomics

ABSTRACT: Gene expression linked to competitive performance in fighting cocks

PROVIDER: PRJEB89392 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR14952846_1.fastq.gz	Fastqsanger.gz
	ERR14952846_2.fastq.gz	Fastqsanger.gz
	ERR14952847_1.fastq.gz	Fastqsanger.gz
	ERR14952847_2.fastq.gz	Fastqsanger.gz
	ERR14952848_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Paeonia lactiflora isolate:Paeonia lactiflora Command Performance | breed:Command Performance | cultivar:Command Performance

Project description:Paeonia lactiflora isolate:Paeonia lactiflora Command Performance | breed:Command Performance | cultivar:Command Performance Genome sequencing and assembly

| PRJNA1452259 | ENA

Performance Evaluation of Commercial miRNA Expression Array Platforms

2010-03-18 | GSE19248 | GEO

Performance Evaluation of Commercial miRNA Expression Array Platforms

Project description:This data is part of a miRNA platform comparison study. We compared the performance characteristics of four commercial miRNA array technologies and found that all platforms performed well in separate measures of performance. The Ambion and Agilent platforms were more accurate, whereas the Illumina and Exiqon platforms were more specific. Furthermore, the data analysis approach had a large impact on the performance, predominantly by improving precision. Performance of four (4) commercially available miRNA platforms was evaluated using 7 placenta samples spiked with synthetic microRNA spikes (in Latin-square design) absent in placenta. Platforms were primarily evaluated for accuracy and specificity.

2010-06-23 | E-GEOD-19248 | biostudies-arrayexpress

Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Communities Fighting COVID

Project description:Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Communities Fighting COVID

| PRJNA772344 | ENA

Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Communities Fighting COVID

Project description:Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Communities Fighting COVID

| PRJNA772345 | ENA

Music performance regulates microRNAs in professional musicians

Project description:The dataset was used to study the effect of 2 hours of western classical music concert performance on the peripheral blood microRNA transcriptome in professional musicians.

2019-03-04 | GSE115071 | GEO

Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues

Project description:Single-cell transcriptomics has emerged as the preferred tool to define cell identity through the analysis of gene expression signatures. However, there are limited studies that have comprehensively compared the performance of different scRNAseq systems in complex tissues. Here, we present a systematic comparison of three well-established high throughput 3’-scRNAseq platforms: Drop-seq, 10x Chromium and BD Rhapsody; using tumours that present high cell diversity. Our experimental design includes both fresh and artificially damaged samples from the same tumours, which also provides a comparable dataset to examine their performance under challenging conditions. The performance metrics used in this study consist of gene sensitivity, mitochondrial content, reproducibility, clustering capabilities, cell type representation and ambient RNA contamination. These analyses showed that BD Rhapsody and 10x Chromium have similar but higher gene sensitivity than Drop-seq, while BD Rhapsody has the highest mitochondrial content. Interestingly, we found cell type detection biases between platforms, including a lower proportion of endothelial and myofibroblast cells in BD Rhapsody and lower gene sensitivity in granulocytes for 10x Chromium. Moreover, the source of the ambient noise was different between plate-based and droplet-based platforms. In conclusion, our reported platform differential performance should be considered for the selection of the scRNAseq method during the study experimental designs.

2024-09-04 | GSE229765 | GEO

Cellular Feimin enhances exercise performance by suppressing muscle thermogenesis

Project description:Exercise can rapidly increase core body temperature, and research has indicated that elevated internal body temperature can independently contribute to fatigue during physical activity. However, the precise mechanisms responsible for regulating thermogenesis in muscles during exercise have remained unclear. Here, we demonstrate that cellular Feimin (cFeimin) enhances exercise performance by inhibiting muscle thermogenesis during physical activity. Mechanistically, we found that AMPK phosphorylates cFeimin and facilitates its translocation into the cell nucleus during exercise. Within the nucleus, cFeimin binds to the forkhead transcription factor FOXC2, leading to the suppressed expression of Sarcolipin (Sln), which is a key regulator of muscle thermogenesis. In addition, our results further reveal that short-term AMPK agonist treatments can enhance exercise performance through the activation of the AMPK-cFeimin signaling pathway. In summary, these results underscore the crucial role of cFeimin in enhancing exercise performance by modulating SLN-mediated thermogenesis.

2024-11-01 | GSE280845 | GEO

Performance differences in spatial transcriptomics platforms identify Treg biology in human inflammatory bowel disease [Xenium]

Project description:Spatial transcriptomics is a rapidly growing field with the potential to enhance our ability to uncover novel biology, support drug development, and guide biomarker discovery. However, a biologically validated comparison of leading single-cell-level spatial transcriptomics platforms to guide scientists is lacking in the field. Using intestinal biopsies (n = 40) from patients with inflammatory bowel disease (IBD) of varying disease states and disease locations and non-diseased controls, we systematically compared two imaging based spatial transcriptomics platforms (CosMx and Xenium) to guide translational work for two NIDDK supported IBD consortiums and the Crohn’s and Colitis Foundation Plexus Biorepository. In vitro experiments were conducted to validate key biologic findings. We present a comprehensive data resource of over 1.5 million spatially profiled intestinal cells from healthy and IBD samples. We observed CosMx to have overall better data quality than Xenium in both ulcerative colitis and Crohn’s disease across the full spectrum of commercially available panels. The performance of Xenium, but not CosMx, was significantly influenced by block quality and panel size, with a decline in data quality as the panel size increased. We demonstrate operational feasibility for CosMx in multi-center studies, and CosMx uniquely identified Treg-associated biology in both ulcerative colitis and Crohn’s disease which was validated by in vitro experiments. This study highlights the performance differences between CosMx and Xenium, demonstrating the strengths of CosMx for biology discovery in IBD research. Further studies are needed to explore the broader applicability of CosMx in other gastrointestinal conditions.

2026-03-13 | GSE312420 | GEO

Performance differences in spatial transcriptomics platforms identify Treg biology in human inflammatory bowel disease [CosMx]

2026-03-13 | GSE312415 | GEO